In the calendar
Sweden Innovation Days January 17–20
22 December 2021, 09:34
Sweden Innovation Days take place on the 17th – 20th of January. Day 2 of the conference will take a deep dive into how innovation and collaboration are needed to achieve several of the Global Goals and the theme around: 'Preventative health and well-being'.
Europe’s Beating Cancer: implementation roadmap
26 November 2021, 16:34
The European Commission has published an implementation roadmap and progress indicators for Europe’s Beating Cancer Plan to monitor developments on the ten flagship initiatives as well as its other actions.
International collaborations, Prevention
Vision Zero Cancer & OECD OPSI: workshop on mission driven innovation around personalised medicine
08 October 2021, 16:05
Vision Zero Cancer together with OECD Observatory of Public Sector Innovation met together with around 60 participants, speakers, and panellists for a Mission-oriented Innovation Bootcamp.
About Vision Zero Cancer, Press release
Sweden launches testbed for clinical trials in cancer care
24 September 2021, 07:27
Vision Zero Cancer and Genomic Medicine Sweden (GMS) join forces with public sector authorities, regions, healthcare, academia, industry and patient associations to create an innovation milieu that facilitates the introduction of more precise prevention and treatment in cancer care.
About Vision Zero Cancer, Interview
”Breaking new ground on all fronts” – Oncology in Sweden about Vision Zero Cancer
07 July 2021, 17:32
In the latest issue of Oncology in Sweden, a number of people from Vision Zero Cancer were interviewed about the beginning, the vision, how it is going to become reality and the importance of collaboration and inclusiveness to make a change.
Early Detection, International collaborations
Knowledge and experience exchange with Sweden: Early detection of lung cancer in never-smokers
06 July 2021, 17:12
Lung cancer accounts for one in five deaths worldwide. The past few years have seen considerable advances in treatment for lung cancer, yet the prognosis remains low. Lung cancer causes symptoms that come up late in the course of the disease and assessments are complicated. This means that half of the patients have a spread disease at diagnosis.
Estonia-Sweden workshop on cancer – improving health outcomes through innovation and collaboration
26 May 2021, 15:51
The aim of Europe’s Beating Cancer Plan is to tackle the entire disease pathway. Over the coming years, it will focus on research and innovation, tap into the potential that digitalisation and new technologies offer, and mobilise financial instruments to support Member States. With its policy objectives, supported by ten flagship initiatives and multiple supporting actions, the Cancer Plan will help Member States turn the tide against cancer. Sweden and Estonia have decided to join forces in this endeavour.
Interview, Research, clinical trials and registries
Researcher studies Vision Zero Cancer for future innovation
11 May 2021, 13:07
Are milieus like Vision Zero Cancer a good way to accelerate innovation? At Stockholm School of Economics, doctoral student John-Erik Bergkvist is researching this – the methodology for building a vision-driven innovation milieu.
Sweden-Russia experience exchange on lung cancer – accelerating innovation to improve survival and quality of life for people with lung cancer
27 April 2021, 17:18
Around 60 experts gathered during the virtual experience exchange between Sweden and Russia as part of a collaboration between the Association of Oncologists of Russia and Vision Zero cancer, aided by Business Sweden and the Embassy of Sweden to the Russian Federation.
Early Detection, Treatment and quality of life, Workshops
Precision medicine improves cancer care and makes it more equitable and efficient
12 April 2021, 09:11
One size fits all is no longer applicable. Precision medicine has made several advancements in recent years. Rapid development in research and technology is creating conditions for a transformation of the system. With these developments come challenges and consequences – but which ones? And what exactly is accommodated within the concept of precision medicine? These questions where discussed among 60 participants at a digital round table recently hosted by Vision Zero Cancer.